Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in Pittsburgh. In an interview with the Business Times, their CEOs explained why.

The SureScan Microarray Scanner is a key component of Agilent’s complete microarray solution. With improved feature resolution, it delivers exceptional flexibility to analyze any microarray ...

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

Microarray Technology. DNA chips, lab-on-a-chip, microarrays and more. Read all the latest discoveries and research news here. Full-text, images, free.

If you're a woman newly diagnosed with breast cancer, treatment can feel ... well, scary. Will chemotherapy work? Or will it ...

GLP-1 microdosing is when people take smaller doses of GLP-1 drugs than are typically prescribed or FDA-recommended, often ...